Emerging Antiepileptic Drugs for Severe Pediatric Epilepsies

This article reports the clinical trial data and personal experience in treating the severe epilepsies of childhood with the recently Food and Drug Administration-approved new antiepileptic drugs (vigabatrin, rufinamide, perampanel, and clobazam) and those in clinical trials (cannabidiol, stiripentol, and fenfluramine).
Source: Seminars in Pediatric Neurology - Category: Neurology Authors: Source Type: research